[ad_1]
WASHINGTON (USA).- The aspirin, used at low dose, could reduce the severity of the symptoms and abnormalities of the immune system of patients with multiple sclerosis, according to a study published today in the American Journal. Science Signaling magazine.
According to the survey, the aspirin Administered orally to laboratory mice, it reduced the severity of symptoms, slowed the breakdown of myelin and inhibited cell infiltration into the spinal cord.
The amount of aspirin applied to the mice was equivalent to a dose of the infant version of the drug in adults.
The multiple sclerosis is a degenerative disease that affects more than 2.3 million people worldwide and originates in the loss of myelin, a protein in the nervous system responsible for transmitting electrical impulses and protecting neurons.
Researchers Rush University (Chicago) discovered an unknown effect of this common medication, commonly used to relieve pain.
With a small amount, aspirin was able to stimulate the production of positive cells for nerve transmission, while slowing the activity of these malignant cells -Tregg- that attack the nervous system, degrade the metabolism and are responsible for the imbalance that causes the symptoms of multiple sclerosis.
The scientific team, led by Susanta Mondal, He emphasized the safety of the active ingredient of aspirin and its ease of administration, so that it can be reused as a supportive treatment for multiple sclerosis patients and others autoimmune disorders associated with dysfunction of the same Treg cells.
⊕
Source link
